Jean Nachega, MD, PhD
About Jean Nachega, MD, PhD
Dr. Jean Nachega is an associate scientist in the Department of International Health at the Johns Hopkins Bloomberg School of Public Health. He is an Infectious Diseases Internist trained in Epidemiology, Health Economics, Tropical Public Health & Medicine. My research, teaching, and professional activities include planning, design, monitoring, and evaluation of clinical trials, cohort studies & programs for prevention and treatment of HIV/AIDS & Tuberculosis.
Role(s) / Profession(s)
- Academic
Organization
- Johns Hopkins University
Language(s)
- English
Recent Contributions
-
Jean Nachega, MD, PhD replied to "Adherence to ART" in the Adherence & Retention community.
Dear David Any documented reasons (structural? alcohol abuse? etc.) for defaulting ART and/or care? Also documented reasons for failure of social/treatment support strategy (family? friends?)? Best, Jean
-
Jean Nachega, MD, PhD started a discussion "Re: cognitive aspects of medication adherence" in the Adherence & Retention community.
Hello, I am seeking recommendations for literature regarding the cognitive aspects of medication adherence. I am considering both assessment of such barriers and intervention using cognitive techniques. Articles specific to people with HIV are desirable, but those involving medication adherence with other illness populations would be acceptable. Thanks for considering, Megan Wilkins ______________________________ Hi Megan Below for consideration... Best, J. 1. Selnes OA. Neurocognitive aspects of medication adherence in HIV Infection. J Acquir Immune Defic ...
-
Jean Nachega, MD, PhD replied to "Directly observed antiretroviral therapy: a systematic review and meta-analysis of randomised clinical trials" in the Adherence & Retention community.
Thanks Ann. I agree with your comment. For clinical/public health practice, it is important that we have now hard data from both developed & developing countries which sheds lights on this controversial issue in support of earlier expert opinions. Best Wishes for the New Year! Jean
-
Jean Nachega, MD, PhD replied to "Directly observed antiretroviral therapy: a systematic review and meta-analysis of randomised clinical trials" in the Adherence & Retention community.
Dear Ann: Certainly! A workshop at the 5th NIH/NIMH-IAPAC International HIV Treatment Adherence Meeting (Miami, May 23-25, 2010) seems an ideal opportunity. I will make the suggestion to my colleagues on the Program Committee. While providing important and useful information, the recent Lancet paper (Ford et al. 2009) is not the final answer to all questions related to this debate. In meantime, we continue to encourage reactions of GHD members for a healthy and instructive ...
-
Jean Nachega, MD, PhD started a discussion "High Antiretroviral Therapy Adherence Associated with Lower Health Care Costs" in the Adherence & Retention community.
Dear Colleagues High antiretroviral therapy adherence which has been shown to be a major predictor of virological suppression, emergence of HIV drug resistance, disease progression and death, is now associated with lower health care costs in resource-limited settings. My colleagues and I, from Johns Hopkins University, in collaboration with colleagues at the University of Cape Town, South Africa, examined the effect of antiretroviral therapy adherence on direct health care costs and found that antiretroviral therapy ...
Recent Recommendations
- None at this time.